 |
|
First gene therapy for heart failure offered at NewYork-Presbyterian/Columbia
June 19, 2008Could injecting a gene into a patient with severe heart failure reverse their disabling and life-threatening condition? Physician-scientists are setting out to answer that question in a first-ever clinical trial of gene therapy to treat severe heart failure.
NewYork-Presbyterian Hospital/Columbia University Medical Center is the only center in the New York City area where the therapy is currently available.
Patients enrolled in the multicenter CUPID trial (Calcium Up-Regulation by Percutaneous Administration of Gene Therapy in Cardiac Disease) will undergo a minimally invasive cardiac catheterization procedure that will introduce a specially engineered gene that stimulates production of an enzyme necessary for the heart to pump more efficiently.
"This new therapy seeks to replenish the levels of this enzyme by introducing the gene for SERCA2a, which is depressed in these patients. If proven effective, this approach could be an alternative to heart transplant for patients without any other options," says Dr. Donna Mancini, the study's principal investigator at NewYork-Presbyterian Hospital/Columbia University Medical Center, where she is medical director of cardiac transplantation. She also is professor of medicine at Columbia University College of Physicians and Surgeons.
Gene therapy is a technique for correcting defective genes responsible for disease development by inserting genes into a patient's cells and tissues. In most gene therapy studies, a "normal" gene is inserted into the genome to replace an "abnormal" disease-causing gene. A carrier molecule called a vector must be used to deliver the therapeutic gene to the patient's target cells. Currently, the most common vector is a non-pathogenic virus most people have been exposed to in adolescence that has been genetically altered to carry normal human DNA.
More than five million people in the U.S. have heart failure. Patients with severe form of the disease have trouble breathing because the heart cannot pump fluid out of their lungs. Seventy percent die of the disease within 10 years, and the five-year survival rate is less than 50 percent. Heart failure is the only cardiovascular disease whose incidence has been increasing rather than decreasing.
New York- Presbyterian Hospital/Columbia University Medical Center
"This new therapy seeks to replenish the levels of this enzyme by introducing the gene for SERCA2a, which is depressed in these patients. If proven effective, this approach could be an alternative to heart transplant for patients without any other options," says Dr. Donna Mancini, the study's principal investigator at NewYork-Presbyterian Hospital/Columbia University Medical Center, where she is medical director of cardiac transplantation. She also is professor of medicine at Columbia University College of Physicians and Surgeons.
Gene therapy is a technique for correcting defective genes responsible for disease development by inserting genes into a patient's cells and tissues. In most gene therapy studies, a "normal" gene is inserted into the genome to replace an "abnormal" disease-causing gene. A carrier molecule called a vector must be used to deliver the therapeutic gene to the patient's target cells. Currently, the most common vector is a non-pathogenic virus most people have been exposed to in adolescence that has been genetically altered to carry normal human DNA.
More than five million people in the U.S. have heart failure. Patients with severe form of the disease have trouble breathing because the heart cannot pump fluid out of their lungs. Seventy percent die of the disease within 10 years, and the five-year survival rate is less than 50 percent. Heart failure is the only cardiovascular disease whose incidence has been increasing rather than decreasing.
New York- Presbyterian Hospital/Columbia University Medical Center
Heart Failure Current Events and Heart Failure News RSSNew hope for cancer comes straight from the heart
Digitalis-based drugs like digoxin have been used for centuries to treat patients with irregular heart rhythms and heart failure and are still in use today. In the Dec. 16 issue of the Proceedings of the National Academy of Sciences, researchers at the Johns Hopkins University School of Medicine now report that this same class of drugs may hold new promise as a treatment for cancer.
New appropriate use criteria guide treatment of patients with heart blockage
If you're committed to fitness, the decision to climb a couple of flights of stairs rather than take the elevator is clear. But if you develop chest pain on the way up, deciding how to treat the symptoms of clogged arteries in your heart is much more complicated.
Arousal frequency in heart failure found to be a unique sleep problem
A study in the Jan. 1 issue of the journal Sleep demonstrates that the frequent arousals from sleep that occur in heart failure patients with central sleep apnea (CSA) may reflect the presence of another underlying arousal disorder rather than being a defensive mechanism to terminate apneas.
Simple Model Predicts Those at Risk for Chronic Kidney Disease
Traditionally, doctors have had no clear way to predict which of their patients might be headed down the road to chronic kidney disease (CKD).
Implantable monitor may help in managing diastolic heart failure
An implantable hemodynamic monitor (IHM) may help to guide medical treatment in a large subgroup of patients with heart failure-those with diastolic heart failure (DHF).
Study finds treatment fails to improve common form of heart failure
A medication used for high blood pressure does not improve a common form of heart failure, according to new results from a large, international study.
Vitamin E shows possible promise in easing chronic inflammation
With up to half of a person's body mass consisting of skeletal muscle, chronic inflammation of those muscles - which include those found in the limbs - can result in significant physical impairment.
Fruit fly research may lead to better understanding of human heart disease
Researchers at the Burnham Institute for Medical Research (Burnham) have shown in both fruit flies and humans that genes involved in embryonic heart development are also integral to adult heart function. The study, led by Rolf Bodmer, Ph.D., was published in Proceedings of National Academy of Sciences.
Mini heart attacks lessen damage from major ones
Researchers have discovered one potential mechanism by which briefly cutting off, then restoring, blood flow to arteries prior to a heart attack lessens the damage caused, according to a study published today in the journal Cardiovascular Research.
Mechanisms of cardiovascular disease and cancer give clues to new therapies
Cardiovascular conditions leading to heart attacks and strokes are treated quite separately from common cancers of the prostate, breast or lung, but now turn out to involve some of the same critical mechanisms at the molecular level.
More Heart Failure Current Events and Heart Failure News Articles
 | Success with Heart Failure (mass mkt ed): Help and Hope for Those with Congestive Heart Failure by Marc Silver Up-to-date information on available and forthcoming medical and surgical treatments. How attitude and emotion affect heart failure--and what you can do to stay positive. Tips for adopting a heart-healthy diet and lifestyle. Ways to forge a positive working relationship with your doctor or cardiologist.... |
 | Clinical Management of Heart Failure, Second Edition by James B. Young, Roger M. Mills The various classes of medications employed in the treatment of heart failure are reviewed as well as the clinical trials shaping heart failure therapeutics. Appropriate staging of therapeutics is discussed along with rational polypharmacy. Treatment options for advanced heart failure are concisely... |
 | MemoCharts Pharmacology: Drug Therapy for Congestive Heart Failure (Review chart) by Howard Shen |
 | Heart Failure: A Practical Approach to Treatment by William Abraham, Henry Krum The definitive one-stop guide to treating -- and preventing -- heart failure. . This practical reference provides all the expert guidance and up-to-the-minute clinical perspectives you need to diagnose, treat, and manage patients with heart failure.. A major focus of the book is integration of various management approaches to maximize patient benefit. Coverage begins with a brief introduction... |
 | Resynchronization and Defibrillation for Heart Failure: A Practical Approach by David L. Hayes, Paul J. Wang, Jonathan Sackner-Bernstein, Samuel J. Asirvatham Resynchronization and Defibrillation for Heart Failure: A Practical Approach is one of the first texts to provide caregivers with information about the background and application of this new and rapidly expanding discipline. Its five authors are cardiologists who have expertise in device management, electrophysiology, and heart failure management. The text integrates the approach and management... |
 | Atlas of Electrophysiology in Heart Failure Heart Failure has emerged as a major cardiovascular health problem. Clinical cardiology has become progressively subdivided into more highly specialized domains, yet the modern management of the heart failure patient crosses these boundaries. Given the cross-disciplinary nature of heart failure management, the Atlas of Electrophysiology in Heart Failure, which explores current concepts in the... |
 | Heart Failure: Pathophysiology, Molecular Biology, and Clinical Management (HEART FAILURE: PATHOPHYSIOLOGY, MOLEC BIOL & CLIN MGT) by Arnold M Katz, Marvin A Konstam This Second Edition of Dr. Katz's highly acclaimed text has been thoroughly revised to incorporate the latest advances in the study and treatment of heart failure. The book explains the pathophysiology, molecular mechanisms, clinical manifestations, and therapy of heart failure in an integrated, reader-friendly manner that is accessible to both clinicians and basic scientists. More than 100... |
 | Heart Failure: A Clinical Nursing Handbook (Wiley Series in Nursing) by Christopher Nicholson This book provides a complete, easy-to-use handbook for nurses who see patients with heart failure. In recent years heart failure has become a high priority in health care. With more nurses caring for patients with heart failure and making decisions that are often complex, there is a clear need for those nurses to have access to good quality clinical information and guidance. This book is... |
 | Heart Failure in the Elderly, An Issue of Heart Failure Clinics (The Clinics: Internal Medicine) by W. S. Aronow |
 | Diastology: Clinical Approach to Diastolic Heart Failure by Allan L. Klein, Mario J. Garcia This reference thoroughly equips you to successfully diagnose and manage even the most complex incidences of diastolic heart failure and their comorbidities. It examines the basic mechanisms of this condition through discussions of both cellular and anatomic causes; guides you through non-invasive techniques for diagnosis, including echocardiography, cardiac CT, and MRI; and provides expert... |
| © 2009 BrightSurf.com |